CMIP and cholangiocarcinoma: Importantly, a panel comprised of CMIP, NME1 and CKS1B provided the maximum diagnostic capacity (AUC: 1.000) for CCA in comparison with the group containing healthy individuals and patients with PSC and UC (Figure 5F).